The current price of BLLN is $109.10 — it has decreased by 4.21% since the previous close. Data as of Nov 5, 2026.
BLLN is down 4.14% over the past week, down 0.42% over the past month and down 0.31% over the past year. The price is above its 200-day moving average of $96.76.
Analysts' average 12-month price target for BLLN is $126.00, which implies 15.49% upside from the current price. Individual estimates range from $120.00 to $130.00.
BillionToOne, Inc. has a market capitalization of $5.15B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, BillionToOne, Inc. posted earnings of $0.32 per share against an estimate of $0.146, beating expectations by 119.18%. Upcoming reports are listed in the earnings calendar.
BillionToOne, Inc. reported revenue of $122.98M in its most recent quarter, which has increased by 47.28% compared with the same quarter a year earlier. Analysts had expected $115.8M.
BillionToOne, Inc. has not paid any dividends over the past year.
Companies most comparable to BillionToOne, Inc. include Natera, Inc., Guardant Health, Inc., GRAIL Inc., Veracyte, Inc. and NeoGenomics, Inc.
In the latest trading session BLLN moved between $100.15 and $112.17, a range of 11.02% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of BillionToOne, Inc. shows a buy rating today and a buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks BLLN has traded between $61.96 and $150.44. The current price is 27.48% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.